IGF2BP2 Drives Cell Cycle Progression in Triple-Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A-Modified CDK6 Translation Initiation Process

By
Bob
-
0
171
Investigators found that IGF2BP2 was highly expressed in TNBC due to the lower methylation level in its promoter region.
[Advanced Science]
Full Article